Kangmei Pharma | 600518 - Ebit



Kangmei Pharma reported CNY-3262057.35 in EBIT for its fiscal quarter ending in September of 2024.

Ebit Change Date
Alaunos Therapeutics USD -7234000 993K Sep/2023
Avita Medical AUD -14013000 3.26M Jun/2024
Cspc Pharmaceutical CNY 1.63B 400.11M Jun/2024
Dianthus Therapeutics USD -22204000 4.36M Jun/2024
Genomma Lab Internacional MXN 1.16B 111.29M Sep/2024
Hypermarcas BRL 711.58M 79.23M Jun/2024
Ionis Pharmaceuticals USD -148000000 104.58M Sep/2024
IQVIA Holdings USD 788M 189M Sep/2024
Jiangsu Hengrui CNY 1.29B 969.4M Sep/2024
Kangmei Pharma CNY -3262057.35 15.91M Sep/2024
Moderna USD -70000000 1.2B Sep/2024
Organon & Co USD 366M 1000K Jun/2024
Revvity USD 193.5M 82.12M Sep/2024
Sh Fosun Pharma CNY 1.44B 169.81M Sep/2024
Tectonic Therapeutic USD -11421000 3.48M Jun/2024
Viatris USD 1.14B 26M Sep/2024
Wuxi Apptec CNY 3.35B 763.92M Sep/2024
Xeris Pharmaceuticals USD -6292000 5.35M Jun/2024
Zz Pientze Pharmaceu 1.13B 228.07M Sep/2024